# 1.1 Definitions and Classifications

### 定义：A Clinical trial/study is any investigation **in** human subjects intended to

* discover or verify the clinical, pharmacological\(药理学的\), and/or other pharmacodynamic\(药效的\) effects of an **investigational product\(s\)**

> 药理学/药效学效应指的是physiological and/or biochemical changes in the body induced by drug

* and/or to identify any adverse reactions to an investigational product\(s\), and/or to study absorption\(吸收\), distribution, metabolism\(新陈代谢\), and excretion\(分泌\) of an investigational product\(s\) with the object of ascertaining\(确定\) its safety and/or efficacy\(药物的功效\).

### A controlled trial

The control group is essential to serve as **standard or baseline** for ascertaining the effects. Besides, control any external factors.

> 注意：试验设计能够控制这种潜在的安慰剂作用\(placebo effect\)，而不损害实现研究目标的能力，这一点很重要。例如周期太短，treatment和placebo效果没有差别，此时容易得出treatment无效的结论。

### A randomized trial

The most important advantage of proper randomization is that it **minimizes allocation bias**, balancing both known and unknown prognostic factors, in the assignment of treatments.

> 注意：时间上在assessment of eligibility and recruitment之后，intervention之前。nonrandomized一般用于exploratory use。尽管存在混杂因素\(confounder\)，但当随机分配unethical的时候，这是唯一选择。

### 对比：Interventional vs Non-Interventional

<table>
  <thead>
    <tr>
      <th style="text-align:left">Non- Interventional&#xFF08;&#x975E;&#x5E72;&#x9884;&#x6027;&#x53C8;&#x540D;&#x89C2;&#x5BDF;&#x6027;&#xFF09;</th>
      <th
      style="text-align:left">Low- Interventional/Pragmatic</th>
        <th style="text-align:left">Interventional</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="text-align:left">
        <p>Exposure is not conditionned by protocol</p>
        <p>&#x66B4;&#x9732;&#x4E0D;&#x53D7;&#x534F;&#x8BAE;&#x7684;&#x9650;&#x5236;</p>
      </td>
      <td style="text-align:left">
        <p>Exposure is not conditionned by protocol</p>
        <p>&#x66B4;&#x9732;&#x4E0D;&#x53D7;&#x534F;&#x8BAE;&#x7684;&#x9650;&#x5236;</p>
      </td>
      <td style="text-align:left">
        <p>Exposure is conditionned by protocol</p>
        <p>&#x66B4;&#x9732;&#x53D7;&#x5230;&#x534F;&#x8BAE;&#x7684;&#x9650;&#x5236;</p>
      </td>
    </tr>
    <tr>
      <td style="text-align:left">
        <p>Investigational product is approved in the indication (purpose is not
          to investigate B/R of off-label use)</p>
        <p>&#x76EE;&#x7684;&#x4E0D;&#x662F;&#x4E3A;&#x4E86;&#x6D4B;&#x91CF;&#x4E34;&#x5E8A;&#x8BD5;&#x9A8C;&#x4E4B;&#x5916;&#x7684;&#x7528;&#x9014;</p>
      </td>
      <td style="text-align:left">
        <p>Investigational product is approved in the indication--No placebo</p>
        <p>&#x6D4B;&#x8BD5;&#x4EA7;&#x54C1;&#x901A;&#x8FC7;&#xFF0C;&#x6CA1;&#x6709;&#x5B89;&#x6170;&#x5242;</p>
      </td>
      <td style="text-align:left">
        <p>Investigational product is approved or non-approved in the indication</p>
        <p>&#x6D4B;&#x8BD5;&#x4EA7;&#x54C1;&#x901A;&#x8FC7;&#x6216;&#x4E0D;&#x901A;&#x8FC7;&#xFF0C;&#x57FA;&#x4E8E;</p>
      </td>
    </tr>
    <tr>
      <td style="text-align:left">
        <p>Outcomes are defined and measured according to standard medical practice</p>
        <p>&#x6839;&#x636E;&#x6807;&#x51C6;&#x533B;&#x5B66;&#x5B9E;&#x8DF5;&#x8BC4;&#x4F30;&#x7ED3;&#x679C;</p>
      </td>
      <td style="text-align:left">
        <p>Outcomes are defined and measured according to a predefined protocol</p>
        <p>&#x6839;&#x636E;&#x9884;&#x5148;&#x5B9A;&#x4E49;&#x7684;&#x534F;&#x8BAE;&#x6765;&#x8BC4;&#x4F30;&#x7ED3;&#x679C;</p>
      </td>
      <td style="text-align:left">
        <p>Outcomes are defined and measured according to a predefined protocol</p>
        <p>&#x6839;&#x636E;&#x9884;&#x5148;&#x5B9A;&#x4E49;&#x7684;&#x534F;&#x8BAE;&#x6765;&#x8BC4;&#x4F30;&#x7ED3;&#x679C;</p>
      </td>
    </tr>
    <tr>
      <td style="text-align:left">
        <p>No additional diagnostic or monitoring procedure to normal clinical practice</p>
        <p>&#x6CA1;&#x6709;&#x989D;&#x5916;&#x7684;&#x9488;&#x5BF9;&#x5E38;&#x89C4;&#x4E34;&#x5E8A;&#x5B9E;&#x8DF5;&#x7684;&#x5176;&#x4ED6;&#x8BCA;&#x65AD;&#x6216;&#x76D1;&#x6D4B;&#x7A0B;&#x5E8F;</p>
      </td>
      <td style="text-align:left">
        <p>The additional diagnostic or monitoring procedures do not pose more than
          minimal additional risk or burden to the safety of the subjects compared
          to normal clinical practice in any Member State concerned
          <br />&#x4E0E;&#x4EFB;&#x4F55;&#x76F8;&#x5173;&#x4F1A;&#x5458;&#x56FD;&#x7684;&#x6B63;&#x5E38;&#x4E34;&#x5E8A;&#x5B9E;&#x8DF5;&#x76F8;&#x6BD4;&#xFF0C;&#x989D;&#x5916;&#x7684;&#x8BCA;&#x65AD;&#x6216;&#x76D1;&#x6D4B;&#x7A0B;&#x5E8F;&#x4E0D;&#x4F1A;&#x7ED9;&#x53D7;&#x8BD5;&#x8005;&#x7684;&#x5B89;&#x5168;&#x5E26;&#x6765;&#x6700;&#x5C0F;&#x7684;&#x989D;&#x5916;&#x98CE;&#x9669;&#x6216;&#x8D1F;&#x62C5;</p>
        <p></p>
      </td>
      <td style="text-align:left"></td>
    </tr>
  </tbody>
</table>> Non-Interventional使用流行病学方法来分析收集的数据，分为prospective研究和retrospective研究。对于回顾性研究，由于数据的二次使用secondary use（收集数据的主要原因不是出于特定的研究目的），混淆和偏见的风险更高。
>
> 对interventional的批评之一就是overestimate治疗方案的实际风险收益（the actual benefits-risks）

### blinding

1. Open-label：All parties involved with the trial know which participants have been assigned which interventions.
2. Observer-blind：The caregiver and the outcome assessor do not know which participants have been assigned which interventions.
3. Single-blind：One party involved with the clinical trial, either the investigator or participant, does not know which participants have been assigned which interventions.
4. **Double-blind**：Two or more parties involved with the clinical trial do not know which participants have been assigned which interventions. Typically, this includes the investigator and participant.

{% hint style="info" %}
**double-blinding is best as it minimises the conscious and unconscious bias during the clinical trial with regard to treatment effect.**
{% endhint %}

### 总结

<table>
  <thead>
    <tr>
      <th style="text-align:left">Interventional</th>
      <th style="text-align:left">Non-interventional&#xFF08;&#x53C8;&#x540D;&#x89C2;&#x5BDF;&#x6027;&#x7814;&#x7A76;&#xFF09;</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="text-align:left">
        <p>RCT: Randomized clinical/controlled trials</p>
        <p>PCT: Pragmatic clinical trials &#x5B9E;&#x7528;&#x4E34;&#x5E8A;&#x8BD5;&#x9A8C;</p>
        <p>LICT: Low-interventional clinical trials &#x4F4E;&#x5E72;&#x9884;&#x6027;</p>
      </td>
      <td style="text-align:left">
        <p>NISPD: Non-Interventional Study Primary use of Data</p>
        <p>NISSD : Non-Interventional Study Secondary use of Data</p>
        <p>ODS: Observational database studies</p>
        <p>ODA: Observational database analyses</p>
        <p>PMS: Post marketing surveillance</p>
        <p>PASS/PAES: Post approval safety/effectiveness study</p>
      </td>
    </tr>
    <tr>
      <td style="text-align:left">more controlled</td>
      <td style="text-align:left">less controlled</td>
    </tr>
    <tr>
      <td style="text-align:left">Primary data collection</td>
      <td style="text-align:left">Secondary use of data</td>
    </tr>
    <tr>
      <td style="text-align:left">Prospective</td>
      <td style="text-align:left">Retrospective</td>
    </tr>
  </tbody>
</table>